Jeffrey S Farrow sold $440K of Tarsus Pharmaceuticals (TARS)

Executed Mar 17, disclosed Mar 19, 2 days later.

Value, as filed

$440K

6,430 sh across 3 lots

Executed

Mar 17

the trade date, as filed

Disclosed

Mar 19

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jeffrey S Farrow See Remarks profile →

Jeffrey S Farrow (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $877K of TARS (14,396 sh × $60.95, as filed), executed Jun 16.

The name

TARS

Tarsus Pharmaceuticals, Inc. TARS · Healthcare · 35 filings in 24 months ticker →

Healthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey S Farrow in TARS

TARSSALE Tarsus Pharmaceuticals, Inc. $877K
14,396 sh × $60.95
Exec Jun 16
Filed Jun 17 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $550K
13,608 sh × $40.42
Exec Jun 17 2025
Filed Jun 18 2025 · 5:30 PM ET